Introduction
A preclinical plan should do more than list experiments. Its purpose is to organise evidence generation around the decisions a company expects to make. A decision-ready plan begins with the development question rather than the experimental technique.
Start with the decision
The first question should not be “Which study can we run?” It should be “Which decision must the program support?” Defining the decision reveals which uncertainties are material and which data would meaningfully reduce them.
Separate evidence from assumption
Most early programs contain observed findings, accepted context, untested assumptions and working hypotheses. A useful plan distinguishes what has been demonstrated, what appears likely, what is unknown and which unknowns could change the development path.
Define the role of each study
Every study should have a primary question, model rationale, key endpoints, expected interpretation, limitations and a clear decision consequence.
Include dependencies and sequence
Formulation, bioanalytical readiness and early exposure data can determine when later work should begin. Mapping these dependencies reduces avoidable delay.
Define decision criteria before data arrive
Criteria should clarify which findings support continuation, require investigation, change the sequence, trigger an alternative strategy or stop a line of development.
Keep the plan proportionate
The appropriate evidence depends on stage, uncertainty, resources and consequences of being wrong. The aim is enough reliable information for the next important decision.
Conclusion
The strongest plans connect questions, studies, dependencies and decisions in one coherent framework.